SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-038856
Filing Date
2019-10-31
Accepted
2019-10-30 18:04:14
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20190930.htm   iXBRL 10-Q 2017684
2 EX-31.1 acad-ex311_8.htm EX-31.1 9482
3 EX-31.2 acad-ex312_6.htm EX-31.2 9223
4 EX-32.1 acad-ex321_7.htm EX-32.1 6344
5 EX-32.2 acad-ex322_9.htm EX-32.2 6399
  Complete submission text file 0001564590-19-038856.txt   6675100

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acad-20190930.xsd EX-101.SCH 39188
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20190930_cal.xml EX-101.CAL 57242
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20190930_def.xml EX-101.DEF 93442
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20190930_lab.xml EX-101.LAB 315774
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20190930_pre.xml EX-101.PRE 228169
12 EXTRACTED XBRL INSTANCE DOCUMENT acad-10q_20190930_htm.xml XML 1286074
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 191181396
SIC: 2834 Pharmaceutical Preparations